Foreign produced COVID-19 vaccines: Decision on emergency use applications to be taken in three days
The Hindu
Health Ministry issued regulatory pathways for foreign produced COVID-19 vaccines according to which the CDSCO has prepared detailed guidelines specifying regulatory pathway
India’s drug regulator will take a decision on applications seeking approval for restricted emergency use of foreign produced COVID-19 vaccines within three working days from the date of submission, the government said on April 15. The moves comes at a time when India is battling a surge in COVID-19 cases with over two lakh cases reported in a single day on April 15, taking the total number of cases to 1,40,74,564. The Central Drugs Standard Control Organisation (CDSCO), which is headed by the Drug Controller General of India (DCGI), will process applications for registration certificate (registration of overseas manufacturing site and product; in this case COVID-19 vaccine) and import license within three working days from the date of approval of restricted use in emergency situation.More Related News